[{"address1": "2000 Powell Street", "address2": "Suite 1150, eleventh floor", "city": "Emeryville", "state": "CA", "zip": "94608", "country": "United States", "phone": "510 899 8800", "fax": "510 474 1577", "website": "https://novabay.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "NovaBay Pharmaceuticals, Inc. manufactures and sells wound care products. The company offers hypochlorous acid for use in the cleansing and irrigation of post-surgical wounds, minor burns, and superficial abrasions. It sells its products to its distribution partners in China. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.", "fullTimeEmployees": 13, "companyOfficers": [{"maxAge": 1, "name": "Mr. Tommy  Law", "age": 39, "title": "Controller, Interim CFO & Treasurer", "yearBorn": 1986, "fiscalYear": 2024, "totalPay": 220196, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Michael  Kazley", "title": "CEO & Director", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.51, "open": 0.56, "dayLow": 0.5063, "dayHigh": 0.746, "regularMarketPreviousClose": 0.51, "regularMarketOpen": 0.56, "regularMarketDayLow": 0.5063, "regularMarketDayHigh": 0.746, "exDividendDate": 1759190400, "payoutRatio": 0.0, "beta": 0.007, "trailingPE": 0.023302326, "forwardPE": -0.73317075, "volume": 7798900, "regularMarketVolume": 7798900, "averageVolume": 1923168, "averageVolume10days": 1691350, "averageDailyVolume10Day": 1691350, "bid": 0.6, "ask": 0.6198, "bidSize": 1100, "askSize": 100, "marketCap": 15584157, "fiftyTwoWeekLow": 0.46, "fiftyTwoWeekHigh": 19.95, "allTimeHigh": 130156.25, "allTimeLow": 0.36, "priceToSalesTrailing12Months": 1.5127312, "fiftyDayAverage": 4.7388, "twoHundredDayAverage": 1.9688, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 78735664, "profitMargins": 0.31479, "floatShares": 10242154, "sharesOutstanding": 25921751, "sharesShort": 540352, "sharesShortPriorMonth": 272395, "sharesShortPreviousMonthDate": 1767139200, "dateShortInterest": 1769731200, "sharesPercentSharesOut": 0.0214, "heldPercentInsiders": 0.91872, "heldPercentInstitutions": 0.05455, "shortRatio": 1.19, "shortPercentOfFloat": 0.0216, "impliedSharesOutstanding": 25921751, "bookValue": -0.446, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -6985000, "trailingEps": 25.8, "forwardEps": -0.82, "lastSplitFactor": "1:35", "lastSplitDate": 1717113600, "enterpriseToRevenue": 7.643, "enterpriseToEbitda": -15.429, "52WeekChange": -0.22388059, "SandP52WeekChange": 0.11527538, "lastDividendValue": 0.8, "lastDividendDate": 1759190400, "quoteType": "EQUITY", "currentPrice": 0.6012, "recommendationKey": "none", "totalCash": 2309000, "totalCashPerShare": 0.018, "ebitda": -5103000, "totalDebt": 970000, "quickRatio": 1.894, "currentRatio": 2.001, "totalRevenue": 10302000, "debtToEquity": 59.364, "revenuePerShare": 1.482, "returnOnAssets": -0.86977, "returnOnEquity": -5.1626, "grossProfits": 6523000, "freeCashflow": -2638125, "operatingCashflow": 2957000, "revenueGrowth": -0.787, "grossMargins": 0.63318, "ebitdaMargins": -0.49534, "operatingMargins": -2.24376, "financialCurrency": "USD", "symbol": "NBY", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "NovaBay Pharmaceuticals, Inc.", "longName": "NovaBay Pharmaceuticals, Inc.", "regularMarketChangePercent": 17.8824, "regularMarketPrice": 0.6012, "marketState": "CLOSED", "exchange": "ASE", "messageBoardId": "finmb_32625201", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "corporateActions": [{"header": "Reverse stock split", "message": "NBY announces 1 for 5 split effective Feb. 23, 2026", "meta": {"eventType": "SPLIT", "dateEpochMs": 1771822800000, "splitRatio": "1:5"}}], "postMarketTime": 1771635017, "regularMarketTime": 1771621200, "fiftyDayAverageChange": -4.1376, "fiftyDayAverageChangePercent": -0.8731324, "twoHundredDayAverageChange": -1.3676, "twoHundredDayAverageChangePercent": -0.69463634, "priceToBook": -1.347982, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1193405400000, "postMarketChangePercent": -1.8629426, "postMarketPrice": 0.59, "postMarketChange": -0.011200011, "regularMarketChange": 0.0912, "regularMarketDayRange": "0.5063 - 0.746", "fullExchangeName": "NYSE American", "averageDailyVolume3Month": 1923168, "fiftyTwoWeekLowChange": 0.14119998, "fiftyTwoWeekLowChangePercent": 0.30695647, "fiftyTwoWeekRange": "0.46 - 19.95", "fiftyTwoWeekHighChange": -19.3488, "fiftyTwoWeekHighChangePercent": -0.96986467, "fiftyTwoWeekChangePercent": -22.38806, "dividendDate": 1759104000, "earningsTimestampStart": 1755025200, "earningsTimestampEnd": 1755025200, "earningsCallTimestampStart": 1723581000, "earningsCallTimestampEnd": 1723581000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 25.8, "epsForward": -0.82, "displayName": "NovaBay Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2026-02-21"}]